Filing Details
- Accession Number:
- 0001179110-20-009199
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-20 16:40:15
- Reporting Period:
- 2020-08-18
- Accepted Time:
- 2020-08-20 16:40:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1017832 | P Martin Sutter | 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Disposition | 2020-08-18 | 750 | $311.99 | 187,760 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-08-18 | 750 | $0.00 | 187,010 | No | 4 | G | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-08-19 | 750 | $312.38 | 186,260 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2020-08-19 | 750 | $0.00 | 185,510 | No | 4 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct |
Footnotes
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the sale price of the transactions on the reported date at $311.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This transaction represents a donation to a charity
- This price represents the sale price of the transactions on the reported date at $312.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
